Search Results 391-400 of 22983 for Phase

  1. Open-label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T-cells (CT053) in Patients

    Open-label, Multi-center, Phase 1b/2 Clinical Trial to Evaluate the Safety and Efficacy of Autologous CAR-BCMA T-cells (CT053) in Patients.

  2. Study To Evaluate Efficacy And Safety Of ONL1204 In Patients With GA Associated With AMD - Mayo Clinic

    There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should ...

  3. A 2-stage, Phase III Study To Investigate The Efficacy And Safety Of Anifrolumab In Adults With Chronic And/​or Subacute Cutaneous Lupus Erythematosus (LAVENDER) - Mayo Clinic

    A 2-stage, Phase III Study To Investigate The Efficacy And Safety Of Anifrolumab In Adults With Chronic And/​or Subacute Cutaneous Lupus Erythematosus (LAVENDER).

  4. A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable Biliary Tract Cancers - Mayo Clinic

    A Randomized Phase 2 Study of Combination Atezolizumab and CDX-1127 (Varlilumab) With or Without Addition of Cobimetinib in Previously Treated Unresectable ...

  5. Update on Mayo Clinic's COVID-19 vaccination plans

    National vaccination phases 2 to 4 are yet to be finalized by ACIP and are only projections at this time: Phase 2: Congregate settings and adults with some ...

  6. A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects With Moderate to Severe Ulcerative Colitis (FIGARO UC 302) - Mayo Clinic

    Clinical Trials · A Phase 3 Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Study of SHP647 as Induction Therapy in Subjects ...

  7. Mayo Clinic responds to next phase of COVID-19 vaccinations in Minnesota

    As a result, Mayo Clinic is moving to the next phase of COVID-19 vaccinations in Minnesota. This announcement comes as Minnesota anticipates a significant ...

  8. The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy - Mayo Clinic

    About this study. The GUARD Trial is a multi-center adaptive Phase 3 clinical trial of repeated intravitreal injections of ADX-2191 for the prevention of ...

  9. A Phase 1/2 Study To Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of HMB-001 In Glanzmann Thrombasthenia - Mayo Clinic

    A Phase 1/2 Study To Investigate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, And Efficacy Of HMB-001 In Glanzmann Thrombasthenia · Share · Facebook ...

  10. Detection of Malignancy in Biliary Brushings Using Genomic Markers: A Phase 1 Study - Mayo Clinic Research

    The purpose of this phase 1 study is to identify a set of genomic markers with the potential to improve the detection of malignancy in a prospectively ...